PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 68 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $215,000 | -86.0% | 10,907 | -83.9% | 0.01% | -83.9% |
| Q2 2015 | $1,533,000 | -70.5% | 67,578 | -71.6% | 0.06% | -65.9% |
| Q4 2014 | $5,196,000 | -26.1% | 237,797 | -18.5% | 0.16% | -45.5% |
| Q2 2014 | $7,028,000 | +16.8% | 291,600 | +22.3% | 0.30% | -10.7% |
| Q1 2014 | $6,017,000 | +1462.9% | 238,409 | -20.1% | 0.34% | +1196.2% |
| Q2 2013 | $385,000 | – | 298,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delaney Dennis R | 60,000 | $25,000 | 0.05% |
| Freedom Investment Management, Inc. | 1,422,314 | $597,000 | 0.04% |
| Sterling Global Strategies LLC | 10,000 | $4,000 | 0.02% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,009,400 | $424,000 | 0.01% |
| CORRADO ADVISORS, LLC | 15,000 | $6,000 | 0.00% |
| First Heartland Consultants, Inc. | 17,240 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 37,955 | $16,000 | 0.00% |
| Commonwealth Equity Services, Inc | 486,961 | $205,000 | 0.00% |
| QS Investors, LLC | 503,400 | $212,000 | 0.00% |
| Perceptive Advisors | 24,332 | $10,000 | 0.00% |